IRadimed (IRMD) Analyst & Key Data

Analyst Consensus

Buy5 analysts

Buy

Updated Sep 12, 2026

Total Analysts5

Buy

2

Ratings

Updated Sep 12, 2026

Overall Rating

B

DCF Score4.0 / 5

Debt / Equity Score1.0 / 5

Price / Book Score1.0 / 5

Price / Earnings Score1.0 / 5

ROA Score5.0 / 5

ROE Score5.0 / 5

Valuation

Current Stock Price

$82.22

Median Target+28.44%

$105.60

Potential upside vs current price

DCF Value-43.14%

$46.75

Potential downside vs current price

Current Stock Price

$82.22

Median Target+28.44%

$105.60

Potential upside vs current price

DCF Value-43.14%

$46.75

Potential downside vs current price

Analyst Consensus

Buy5 analysts

Buy

Updated Sep 12, 2026

Total Analysts5

Buy

2

Ratings

Updated Sep 12, 2026

Overall Rating

B

DCF Score4.0 / 5

Debt / Equity Score1.0 / 5

Price / Book Score1.0 / 5

Price / Earnings Score1.0 / 5

ROA Score5.0 / 5

ROE Score5.0 / 5

Valuation

Current Stock Price

$82.22

Median Target+28.44%

$105.60

Potential upside vs current price

DCF Value-43.14%

$46.75

Potential downside vs current price

Current Stock Price

$82.22

Median Target+28.44%

$105.60

Potential upside vs current price

DCF Value-43.14%

$46.75

Potential downside vs current price

IRadimed Corporation